<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413947"><TermName>gadolinium texaphyrin</TermName><TermPronunciation>(GA-doh-LIH-nee-um tek-SA-fih-rin)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment and diagnosis of some types of cancer. It builds up in some cancer cells, which may make them easier to kill with radiation therapy and chemotherapy. Gadolinium texaphyrin is also used in magnetic resonance imaging (MRI) to help find cancer cells in the body. It is a type of radiosensitizing agent, a type of chemosensitizing agent, and a type of contrast agent. Also called motexafin gadolinium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713525" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gadolinium texaphyrin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713526" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;gadolinio texapirina&quot;" language="es" id="_4"/><SpanishTermName>gadolinio texapirina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento y el diagnóstico de algunos tipos de cáncer. Se acumula en algunas células cancerosas, lo que facilita su destrucción con radioterapia y quimioterapia. La gadolinio texapirina también se usa en las imágenes por resonancia magnética (IRM) para ayudar a identificar células cancerosas en el cuerpo. Es un tipo de radiosensibilizador, un tipo de quimiosensibilizador y un tipo de sustancia de contraste. También se llama gadolinio motexafina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished><DateLastModified>2013-04-01</DateLastModified></GlossaryTerm>
